Inaktiver Wert

Andere Sprachen Achieve Life Sciences Inc Nasdaq

Aktien

US0044681049

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

Delcath Systems Announces Appointment of Bridget Martell, MA, MD to Delcath's Board of Directors	29.05.
Achieve Life Sciences Announces Initiation of ORCA-OL Clinical Trial Evaluating Long-Term Exposure of Cytisinicline in People who Smoke or Use Nicotine E-Cigarettes	29.05.
Achieve Life Sciences, Inc. Announces Initiation of ORCA-OL Clinical Trial Evaluating Long-Term Exposure of Cytisinicline in People who Smoke or Use Nicotine E-Cigarettes	29.05.
Achieve Life Sciences Announces Data from Cytisinicline ORCA-V1 Program to be presented at Society of General Internal Medicine Annual Meeting	20.05.
Achieve Life Sciences : Society of General Internal Medicine (SGIM) Annual Meeting	17.05.
Achieve Life Sciences Announces Data from Cytisinicline ORCA-V1 Program to be Presented at Society of General Internal Medicine (SGIM) Annual Meeting	17.05.
Achieve Life Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09.05.
Achieve Life Sciences Reports Financial Results for First Quarter 2024 and Provides Corporate Update	09.05.
Achieve Life Sciences Announces Publication of Cytisinicline Vaping Cessation Trial Results in JAMA Internal Medicine	06.05.
Achieve Life Sciences, Inc. Announces Publication of Cytisinicline Vaping Cessation Trial Results in JAMA Internal Medicine	06.05.
Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 9, 2024	25.04.
Achieve Life Sciences to Present at Life Science Innovation Northwest 2024 Conference	11.04.
Achieve Life Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28.03.
Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2023 and Provides Corporate Update	28.03.
Achieve Life Sciences, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	28.03.
Achieve Life Sciences Announces Data from Cytisinicline ORCA Program to be Presented at the 2024 Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting	20.03.
Achieve Life Sciences, Inc. Announces Data from Cytisinicline ORCA Program to Be Presented at the 2024 Society for Research on Nicotine and Tobacco Annual Meeting	20.03.
Achieve Life Sciences to Announce Fourth Quarter and Year-End 2023 Financial Results and Host Conference Call and Webcast on March 28, 2024	14.03.
Achieve Life Sciences Announces Participation at Upcoming Investor Conferences	06.03.
Sector Update: Health Care Stocks Decline Late Afternoon	29.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Achieve Life Sciences Inc Nasdaq

Aktien

US0044681049

Andere Sprachen

Filter